Search Results 321-330 of 16744 for alt

1. Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

   Participation eligibility · Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <2.5 x institutional upper limit normal (ULN) · Total serum ...

2. Study To Assess Safety And Efficacy Of GKT137831 In Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   ALT > 3 x ULN. Total bilirubin > 1 x ULN. Planned or current plasmapheresis or other extra-corporeal treatments (e.g., molecular adsorbent recirculation ...

3. Lisdexamfetamine dimesylate (oral route) - Side effects & dosage - Mayo Clinic

   Description. Lisdexamfetamine dimesylate is used to treat attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older.

4. Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect) - Mayo Clinic

   ... (ALT or AST) 3x higher than normal values at screening visit. Liver enzymes (ALT or AST) 3x higher than normal values at screening visit. Subject will be ...

5. Metabolic syndrome - Symptoms & causes - Mayo Clinic

   Having three or more specific risk factors, such as high blood pressure or abdominal fat, boosts your risk of type 2 diabetes and heart disease.

6. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   ALT and AST ≤ 2.5 × upper limit of normal (ULN), with the following exception: Patients with documented liver metastases: AST and/or ALT ≤ 5.0 × ULN.

7. Liver transplant - Doctors & Departments - Mayo Clinic

   Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

8. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma - Mayo Clinic

   ... (ALT) has been set to the value of 45 U/L. No history of congenital prolonged corrected QT (QTc) syndrome, New York Heart Association (NYHA) Class III or IV ...

9. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

   ALT >1.5× upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E for ...

10. PET Scan Imaging in Assessing Response in Patients with Esophageal Cancer Receiving Combination Chemotherapy - Mayo Clinic

    AST/ALT ≤ 2.5 times ULN; Not pregnant or nursing; Negative pregnancy test; No prior malignancy within 5 years, with the exception of basal or squamous cell ...